Chemoinformaics analysis of 2-(METHYLAMINO)-1-PHENYLPROPAN-1-OL
| Molecular Weight | 165.236 | nRot | 3 |
| Heavy Atom Molecular Weight | 150.116 | nRig | 21 |
| Exact Molecular Weight | 165.115 | nRing | 1 |
| Solubility: LogS | -1.576 | nHRing | 0 |
| Solubility: LogP | 0.136 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 28.6039 |
| nHD | 2 | BPOL | 15.6181 |
| QED | 0.131 |
| Synth | 4.677 |
| Natural Product Likeliness | 1.996 |
| NR-PPAR-gamma | 0.251 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.842 |
| HIA | 0.95 |
| CACO-2 | -5.847 |
| MDCK | 0.000103163 |
| BBB | 0.672 |
| PPB | 0.740025 |
| VDSS | 0.568 |
| FU | 0.256499 |
| CYP1A2-inh | 0.017 |
| CYP1A2-sub | 0.071 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.582 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.12 |
| CYP3a4-inh | 0.357 |
| CYP3a4-sub | 0.157 |
| CL | 2.585 |
| T12 | 0.832 |
| hERG | 0.003 |
| Ames | 0.781 |
| ROA | 0.136 |
| SkinSen | 0.028 |
| Carcinogencity | 0.953 |
| EI | 0.007 |
| Respiratory | 0.72 |
| NR-Aromatase | 0.044 |
| Antiviral | No |
| Prediction | 0.893155 |